Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanized Agonistic Anti-CD28 Monoclonal Antibody

EU orphan designation number: EU/3/05/276   
Active ingredient: Humanized Agonistic Anti-CD28 Monoclonal Antibody
Indication: Treatment of B-cell Chronic Lymphocytic Leukaemia (B-CLL)
Sponsor: TeGenero AG
Science Park Wuerzburg, Friedrich-Bergius-Ring 15, D-97076 Würzburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/04/2005 Centralised Orphan - Designation EMEA/OD/091/04 (2005)1205 of 11/04/2005